# FDA Inspection 1166617 - Daxor Corporation - April 07, 2022

Source: https://www.keypedia.com/records/fda_inspections/daxor-corporation/ab6806fb-e0cd-4e0e-8337-dad072412e01
Source feed: FDA_Inspections

> FDA Inspection 1166617 for Daxor Corporation on April 07, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1166617
- Company Name: Daxor Corporation
- Inspection Date: 2022-04-07
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Postmarket Assurance: Devices
- Product Type: Devices
- Office Name: Center for Devices and Radiological Health

## Related Documents

- [FDA Inspection 1166617 - 2022-04-07](https://www.keypedia.com/records/fda_inspections/daxor-corporation/0bb822c5-b027-422c-9c8c-82a744d67515)
- [FDA Inspection 820341 - 2013-02-25](https://www.keypedia.com/records/fda_inspections/daxor-corporation/57788055-2eca-4cf1-ba81-7680efbef323)
- [FDA Inspection 820341 - 2013-02-25](https://www.keypedia.com/records/fda_inspections/daxor-corporation/31a8f421-8197-4862-8a89-b5367296d8c4)
- [FDA Inspection 808994 - 2012-11-27](https://www.keypedia.com/records/fda_inspections/daxor-corporation/7789373e-3f91-4435-83e1-98924591cb77)
- [FDA Inspection 674737 - 2010-08-04](https://www.keypedia.com/records/fda_inspections/daxor-corporation/9c2c1ead-55f3-49d5-a185-dfd8e56abe72)

Company: https://www.keypedia.com/companies/daxor-corporation/b76d5e66-ca74-4d1d-b28f-2c13c9fc56b7

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7